These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8818125)

  • 1. Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia.
    Llewellyn-Thomas HA; Williams JI; Levy L; Naylor CD
    Med Decis Making; 1996; 16(3):262-82. PubMed ID: 8818125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction.
    Emberton M
    Int J Clin Pract; 2010 Sep; 64(10):1425-35. PubMed ID: 20579137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia.
    Schulz MW; Chen J; Woo HH; Keech M; Watson ME; Davey PJ
    J Urol; 2002 Jul; 168(1):155-9. PubMed ID: 12050512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the performance of utility techniques in the absence of a gold standard.
    Giesler RB; Ashton CM; Brody B; Byrne MM; Cook K; Geraci JM; Hanita M; Souchek J; Wray NP
    Med Care; 1999 Jun; 37(6):580-8. PubMed ID: 10386570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.
    Lamers RED; van der Wijden FC; de Angst IB; de Vries M; Cuypers M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Bosch RJLHR; Kil PJM
    Urology; 2020 Mar; 137():138-145. PubMed ID: 31899227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy.
    Manyak MJ; Ackerman SJ; Blute ML; Rein AL; Buesterien K; Sullivan EM; Tanio CP; Strauss MJ
    J Endourol; 2002 Feb; 16(1):51-6. PubMed ID: 11890452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
    Elkin EB; Cowen ME; Cahill D; Steffel M; Kattan MW
    Med Decis Making; 2004; 24(5):504-10. PubMed ID: 15358999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Demography and Personality on Patient Choice of Treatment in Symptomatic Benign Prostate Hyperplasia.
    Kesari D; Benjamin J; Podberezsky A; Yulish E; Lobik L; Sumalinsky D; Cytron S
    Isr Med Assoc J; 2015 Jul; 17(7):433-6. PubMed ID: 26357720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
    Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
    J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
    Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
    N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BPH: new guidelines based on symptoms and patient preference. The Agency for Health Care Policy and Research.
    Roberts RG
    Geriatrics; 1994 Jul; 49(7):24-31. PubMed ID: 7517377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial.
    Bjerklund Johansen TE; Baker TM; Black LK
    BJU Int; 2012 Mar; 109(5):731-8. PubMed ID: 21933326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
    Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.
    Minardi D; Galosi AB; Yehia M; Cristalli A; Hanitzsch H; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2004 Mar; 76(1):11-8. PubMed ID: 15185816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.